Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 67

1.

EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesothelioma.

Tan YC, Srivastava S, Won BM, Kanteti R, Arif Q, Husain AN, Li H, Vigneswaran WT, Pang KM, Kulkarni P, Sattler M, Vaidehi N, Mambetsariev I, Kindler HL, Wheeler DL, Salgia R.

Oncogenesis. 2019 Sep 4;8(9):49. doi: 10.1038/s41389-019-0159-6.

2.

The Mitochondrion as an Emerging Therapeutic Target in Cancer.

Roth KG, Mambetsariev I, Kulkarni P, Salgia R.

Trends Mol Med. 2019 Jul 18. pii: S1471-4914(19)30171-6. doi: 10.1016/j.molmed.2019.06.009. [Epub ahead of print] Review.

PMID:
31327706
3.

Small Cell Lung Cancer Therapeutic Responses Through Fractal Measurements: From Radiology to Mitochondrial Biology.

Mambetsariev I, Mirzapoiazova T, Lennon F, Jolly MK, Li H, Nasser MW, Vora L, Kulkarni P, Batra SK, Salgia R.

J Clin Med. 2019 Jul 16;8(7). pii: E1038. doi: 10.3390/jcm8071038.

4.

Intrinsically Disordered Proteins in Chronic Diseases.

Kulkarni P, Uversky VN.

Biomolecules. 2019 Apr 11;9(4). pii: E147. doi: 10.3390/biom9040147.

5.

Combined Checkpoint Inhibition and Chemotherapy: New Era of 1st-Line Treatment for Non-Small-Cell Lung Cancer.

Wang C, Kulkarni P, Salgia R.

Mol Ther Oncolytics. 2019 Mar 19;13:1-6. doi: 10.1016/j.omto.2019.02.001. eCollection 2019 Jun 28. Review.

6.

Structural and Dynamical Order of a Disordered Protein: Molecular Insights into Conformational Switching of PAGE4 at the Systems Level.

Lin X, Kulkarni P, Bocci F, Schafer NP, Roy S, Tsai MY, He Y, Chen Y, Rajagopalan K, Mooney SM, Zeng Y, Weninger K, Grishaev A, Onuchic JN, Levine H, Wolynes PG, Salgia R, Rangarajan G, Uversky V, Orban J, Jolly MK.

Biomolecules. 2019 Feb 22;9(2). pii: E77. doi: 10.3390/biom9020077.

7.

The DNA walk and its demonstration of deterministic chaos-relevance to genomic alterations in lung cancer.

Hewelt B, Li H, Jolly MK, Kulkarni P, Mambetsariev I, Salgia R.

Bioinformatics. 2019 Aug 15;35(16):2738-2748. doi: 10.1093/bioinformatics/bty1021.

8.

Intrinsically Disordered Proteins and the Janus Challenge.

Kulkarni P, Uversky VN.

Biomolecules. 2018 Dec 18;8(4). pii: E179. doi: 10.3390/biom8040179.

9.

Single Molecule FRET: A Powerful Tool to Study Intrinsically Disordered Proteins.

LeBlanc SJ, Kulkarni P, Weninger KR.

Biomolecules. 2018 Nov 8;8(4). pii: E140. doi: 10.3390/biom8040140. Review.

10.

Inhibiting crosstalk between MET signaling and mitochondrial dynamics and morphology: a novel therapeutic approach for lung cancer and mesothelioma.

Wang J, Mirzapoiazova T, Carol Tan YH, Pang KM, Pozhitkov A, Wang Y, Wang Y, Mambetsariev B, Wang E, Nasser MW, Batra SK, Raz D, Reckamp K, Kulkarni P, Zheng Y, Salgia R.

Cancer Biol Ther. 2018;19(11):1023-1032. doi: 10.1080/15384047.2018.1472193. Epub 2018 Oct 12.

11.

Intrinsically Disordered Proteins: The Dark Horse of the Dark Proteome.

Kulkarni P, Uversky VN.

Proteomics. 2018 Nov;18(21-22):e1800061. doi: 10.1002/pmic.201800061. Epub 2018 Oct 24.

PMID:
30218496
12.

Neonatal Screening for Prevalence of Hearing Impairment in Rural Areas.

Parab SR, Khan MM, Kulkarni S, Ghaisas V, Kulkarni P.

Indian J Otolaryngol Head Neck Surg. 2018 Sep;70(3):380-386. doi: 10.1007/s12070-018-1386-4. Epub 2018 May 4.

13.

Structural metamorphism and polymorphism in proteins on the brink of thermodynamic stability.

Kulkarni P, Solomon TL, He Y, Chen Y, Bryan PN, Orban J.

Protein Sci. 2018 Sep;27(9):1557-1567. doi: 10.1002/pro.3458. Epub 2018 Sep 24. Review.

14.

Prostate-Associated Gene 4 (PAGE4): Leveraging the Conformational Dynamics of a Dancing Protein Cloud as a Therapeutic Target.

Salgia R, Jolly MK, Dorff T, Lau C, Weninger K, Orban J, Kulkarni P.

J Clin Med. 2018 Jun 17;7(6). pii: E156. doi: 10.3390/jcm7060156. Review.

15.

PAGE4 and Conformational Switching: Insights from Molecular Dynamics Simulations and Implications for Prostate Cancer.

Lin X, Roy S, Jolly MK, Bocci F, Schafer NP, Tsai MY, Chen Y, He Y, Grishaev A, Weninger K, Orban J, Kulkarni P, Rangarajan G, Levine H, Onuchic JN.

J Mol Biol. 2018 Aug 3;430(16):2422-2438. doi: 10.1016/j.jmb.2018.05.011. Epub 2018 Jun 5.

16.

Phenotypic Plasticity, Bet-Hedging, and Androgen Independence in Prostate Cancer: Role of Non-Genetic Heterogeneity.

Jolly MK, Kulkarni P, Weninger K, Orban J, Levine H.

Front Oncol. 2018 Mar 6;8:50. doi: 10.3389/fonc.2018.00050. eCollection 2018. Review.

17.

The Genetic/Non-genetic Duality of Drug 'Resistance' in Cancer.

Salgia R, Kulkarni P.

Trends Cancer. 2018 Feb;4(2):110-118. doi: 10.1016/j.trecan.2018.01.001. Epub 2018 Feb 3. Review.

18.

EphB4: A promising target for upper aerodigestive malignancies.

Salgia R, Kulkarni P, Gill PS.

Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):128-137. doi: 10.1016/j.bbcan.2018.01.003. Epub 2018 Jan 31. Review.

19.

Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma.

Kanteti R, Mirzapoiazova T, Riehm JJ, Dhanasingh I, Mambetsariev B, Wang J, Kulkarni P, Kaushik G, Seshacharyulu P, Ponnusamy MP, Kindler HL, Nasser MW, Batra SK, Salgia R.

Cancer Biol Ther. 2018 Apr 3;19(4):316-327. doi: 10.1080/15384047.2017.1416937. Epub 2018 Feb 22.

20.

Lipoma Arborescens - Eyes See What Mind Knows!

Kulkarni HG, Kulkarni GS, Kulkarni PG.

J Orthop Case Rep. 2017 Sep-Oct;7(5):59-62. doi: 10.13107/jocr.2250-0685.896.

Supplemental Content

Loading ...
Support Center